SQSTM1 Activators

SQSTM1 activators refer to a diverse range of chemical compounds that primarily function by influencing the activity of Sequestosome-1 (SQSTM1), also known as p62. This protein plays a pivotal role in cellular autophagy-a natural, regulated mechanism of the cell that removes unnecessary or dysfunctional components. The activators typically exert their effects by modulating pathways that converge on the autophagy-lysosomal system, effectively augmenting the capacity of the cell to undergo autophagy. Consequently, this leads to an upregulation of SQSTM1 activity, either directly or indirectly. Chemicals that fall under this class may operate via multiple mechanisms such as the inhibition of the mammalian target of rapamycin (mTOR), the activation of AMP-activated protein kinase (AMPK), or the modulation of calcium channel activity, among others.

These compounds share a common ability to influence SQSTM1 through the autophagy pathway. For instance, mTOR inhibitors like Rapamycin and Torin1 activate autophagy by inhibiting a key regulatory pathway, thereby allowing SQSTM1 to function more effectively in its role as an autophagy receptor. On the other hand, compounds like Metformin activate AMPK, which in turn promotes autophagy and the associated SQSTM1 activation. Other compounds, such as Trehalose and Spermidine, have more specific mechanisms but ultimately share the end result of autophagy stimulation. Importantly, the categorization as an "SQSTM1 activator" is often contingent on the cellular context and the specific pathways activated or inhibited. Overall, the complex interplay between these chemicals and cellular mechanisms underscores the multifaceted role of SQSTM1 in cellular health.